This Government Contract opportunity from Department Of Health And Human Services was posted on March 14, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

GMP Synthesis of Bulk Drug Testing

Awarded

75N95024R00058Federal

Submission Closed03/14/2025, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715

New

Federal

Prototyping & Pilot Project ExecutionThis subcontract focuses on the prototyping and pilot project execution of innovative construction and delivery capabilities for prime contractors supporting Department of the Air Force 36 CONS projects. Operating under an Other Transaction Agreement framework, the scope of work involves implementing agile construction methods and testing emerging building technologies to deliver functional prototype or pilot-scale facilities. Managed by the Department of Defense agency FA5240 36 Cons Lgc, the project is categorized under NAICS code 541715. The primary objective is to advance construction capabilities through the practical application and testing of new technologies within a specialized military infrastructure context.

POSTED

DEADLINE

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Solicitation # 75N98027R00006OT

National Institutes Of Health Nida

POSTED

DEADLINE

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Solicitation # 75N98027R00006SB

National Institutes Of Health Nida

POSTED

DEADLINE

Bolstering Underutilized Industry by Leveraging Technology Transfer (BUILTT) pilot program

Solicitation # 10292026-LR-27

The Department of Energy, in partnership with the National Nuclear Security Administration, has announced the Bolstering Underutilized Industry by Leveraging Technology Transfer (BUILTT) pilot program. This initiative, conducted by the Nevada National Security Sites, Y-12 National Security Complex, and Kansas City National Security Campus, aims to assist qualified U.S. small and medium-sized businesses in manufacturing low-volume, high-impact technologies developed by DOE/NNSA Labs, Plants, and Sites. These technologies, which include specialized optical imaging, radiation and chemical sensing systems, precision electrical components, and advanced materials, often have limited commercial markets but are critical for government mission requirements. Under the program, selected businesses may receive a Cost Reduction License (CRL) for a nominal fee, granting them the rights to produce specified technologies for sale to the DOE, NNSA, and other government customers at pre-negotiated prices. Eligibility is limited to U.S.-based SMBs, with preference given to those near participating sites or those with SBA 8(a) or HUBZone designations. Interested parties are evaluated based on their technical and manufacturing capabilities, financial capacity, and ability to meet regulatory and security requirements. Responses must be submitted to the Technology Partnerships and Intellectual Property Office by April 1, 2027, and are categorized under NAICS code 541715.

Msts – DOE Contractor

POSTED

DEADLINE

ARTIFICIAL INTELLIGENCE AND NEXT GENERATION DISTRIBUTED COMMAND AND CONTROL

Solicitation # FA875023S7006

The Department of the Air Force, Air Force Materiel Command, AFRL Rome Research Site, is soliciting research and development for Artificial Intelligence and Next Generation Distributed Command and Control under BAA FA8750-23-S-7006. The primary objective is to transform Joint Force Command and Control capabilities by leveraging AI to enhance battlespace assessment, plan selection, and force monitoring in distributed and contested environments. A significant focus is placed on the Battle Management of AI, which seeks technologies to monitor, adapt, and deploy AI capabilities during mission execution to counter model drift and ensure operational safety. This is an open, two-step BAA effective until August 30, 2028, with total estimated funding of approximately $99 million. Individual awards typically range from $200,000 to $20 million and may be awarded as FAR-based procurement contracts, grants, cooperative agreements, or Other Transactions. Initial submissions are limited to three-page white papers, with formal proposals accepted by invitation only. Evaluation is based on a trade-off process considering overall scientific and technical merit, related experience, solution maturity and openness, and cost realism. Prospective offerors must adhere to strict guidelines, including the Gold Standard Science principles for reproducibility and transparency, and must disclose any potential Organizational Conflicts of Interest. Submissions require a CAGE code, unique entity identifier, and an approved DD Form 2345. The government may provide Government Furnished Software for specific technical areas, and all research must comply with National Industrial Security Program standards for the protection of classified information.

POSTED

DEADLINE

Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)

Solicitation # ARPA-H-SOL-26-163

The Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program, issued by the Advanced Research Projects Agency for Health (ARPA-H) under solicitation ARPA-H-SOL-26-163, aims to advance the understanding and treatment of autism by identifying evolving developmental trajectories across the lifespan. The program focuses on the nonlinear interactions between genetic, biological, behavioral, and environmental factors to move toward personalized intervention. The scope of work is divided into four Technical Areas: Multi-Factor Analysis and Trajectory Identification (TA1), Population-Scale Modeling and Data Integration (TA2), Precision Intervention and Trajectory Testing (TA3), and Technologies for Communication, Quality of Life, and Embedded Assessment (TA4). Key deliverables include an operating federated network with at least ten live nodes, open-license data standards, a versioned model registry, and the development of technologies that combine clinical assessment with tools to improve daily function and quality of life. Awards will be made via Other Transaction (OT) instruments to proposers determined to be the most advantageous to the government based on scientific merit, capabilities, price/value analysis, and relevance to the ARPA-H mission. The program utilizes a milestone-based acceptance process with gates at 12, 24, and 48 months. Technical requirements emphasize privacy-preserving linkage, differential privacy, and secure execution. Proposers must be registered in SAM.gov and are required to use specific templates for Solution Summaries, with staggered submission deadlines ranging from October 2026 through January 2027. ARPA-H prioritizes entities that will conduct the funded work within the United States.

Advanced Research Projects Agency For Health (arpa-H)

POSTED

DEADLINE

Japanese Research PartnershipThe Japanese Research Partnership is a subcontract managed by the National Research Foundation of Korea to provide specialized research and facility support for prime contractors involved in International Joint Research Rapid Support Project optical interconnect projects. The scope of work focuses on collaborative research and development of uLED and uOLED technologies, utilizing the infrastructure of a recognized Japanese research institution to conduct joint experimentation and deliver shared data, research findings, and prototype contributions. The project is categorized under NAICS code 541715, with the place of performance located in South Korea. Interested parties should note that the solicitation was posted on October 29, 2026, with a response deadline of November 11, 2026.

National Research Foundation of Korea

POSTED

DEADLINE

2026년도 국제공동연구 신속지원사업 신규과제 공모

Solicitation # 2026-1045

The 2026 International Joint Research Rapid Support Project, solicitation number 2026-1045, is a government-funded initiative managed by the National Research Foundation of Korea and the Ministry of Science and ICT. The project focuses on developing core original technologies for high-density parallel light sources, specifically micro-LED and micro-OLED, for use in AI data center optical interconnects. The total government support funding is 737.5 million KRW for a 16-month performance period running from December 2026 to March 2028. This project is classified as a National Strategic Technology in the semiconductors and next-generation OLED sectors, aiming to advance from Technology Readiness Level 3 to TRL 5. A mandatory requirement for this solicitation is the establishment of an international joint research network with Japanese research institutions to secure expertise in organic light-emitting materials and patents. Technical objectives include developing 32-channel arrays with specific performance targets: transmission speeds exceeding 1 GHz for micro-LED and 0.2 GHz for micro-OLED, and driving energy levels of 1 pJ/bit and 20 pJ/bit respectively. Final acceptance requires the submission of a functional prototype and verification through accredited certification bodies, official test reports, or witnessed self-evaluations. All research achievements and commercialization results must be managed through the Integrated Research Information System (IRIS), and the project is subject to technology fee collection and the 3-book 5-public rule for concurrent research limits.

National Research Foundation of Korea

POSTED

DEADLINE

Transcriptomic & Epigenomic Assay Services

National Institutes Of Health

POSTED

DEADLINE

Genomic Sequencing Services (Whole-Genome & Long-Read)

National Institutes Of Health

POSTED

DEADLINE

Science, Technology & Innovation Data ProviderThis subcontract opportunity with the Government of Canada seeks a Science, Technology and Innovation Data Provider to support prime contractors on Public Services and Procurement Canada information product projects. The selected provider will be responsible for delivering technical datasets, innovation reports, patent data, technical specifications, and comprehensive R&D trend analysis. A critical requirement for this engagement is the provider's ability to enter into a Provider’s Master License Agreement. The project falls under NAICS code 541715 and will be performed within Canada. Interested parties must submit their responses by the deadline of March 31, 2027. This contract focuses on equipping prime contractors with the necessary technical data and innovation metrics to enhance the delivery of government information products.

Government of Canada / Gouvernement du Canada

POSTED

DEADLINE

Highway Safety Research & AnalysisThis subcontract opportunity involves providing specialized research and analysis for prime contractors working on South Dakota Department of Transportation highway safety projects. The primary objective is to evaluate flagger operations to identify safety gaps and establish effectiveness metrics. The selected provider will utilize traffic simulation software to generate data-driven operational recommendations and deliver comprehensive research reports and data analysis summaries. The project is managed under the South Dakota State Government with a response deadline of December 17, 2026. Classified under NAICS code 541715, the contract focuses on technical research and analysis to enhance highway safety protocols within the state.

South Dakota State Government

POSTED

1 day ago

DEADLINE

in about 2 months

AI Contract Overview

Solicitation 75N95024R00058, titled GMP Synthesis of Bulk Drug Testing, is issued by the National Institutes of Health NIDA under the Department of Health and Human Services. The project focuses on the Good Manufacturing Practice synthesis of bulk drug substances, with performance located in North Bethesda, Maryland. The procurement is categorized under NAICS code 541715 and is managed by points of contact Polina Klimenkova and Rob Bailey. Amendment 01 serves to clarify the original request for proposal requirements by addressing specific inquiries. Key clarifications include the definition of batches for compounds such as psilocybin and LAAM, the specific responsibilities of the Principal Investigator regarding FDA submissions, and the requirements for small business subcontracting plans. Despite these clarifications, the proposal submission deadline is maintained as May 3, 2024.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health Nida

Contract Value

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

North Bethesda, MD, USA

Set-Aside

NONE

Awardee

BENUVIA OPERATIONS, LLC

Award Issued Date

03/14/2025, 12:00:00 AM UTC

Documents

75N95024R00058 Amendment 01 - GMP Synthesis of Bulk Drug Substances

amendment

High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update

PhaseAwarded

PostedMar 4

Presolicitation

Type ChangedMar 20

Presolicitation → Solicitation

Notice updatedApr 11

Notice type changed from Solicitation to Special Notice. The notice description changed.

AwardedMar 14

Contract was awarded

Submission Closed

03/14/2025, 12:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida

Contacts2 people available

OfficeBethesda, MD, 20892, USA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida

Office AddressBethesda, MD, 20892, USA

Contacts

Polina Klimenkova

Rob Bailey

Full Description

The National Institute on Drug Abuse (NIDA) intends to solicit proposals using FULL AND OPEN COMPETITIVE procedures from qualified organizations certified under NAICS Code 541715; to manufacture bulk drug substances under Good Manufacturing Practices (GMP). These bulk drug substances will be used to support NIDA preclinical safety testing and subsequent safety and efficacy clinical trials. Please see the attachment for more details.